Literature DB >> 2661945

Endothelin: a potent vasoconstrictor associated with coronary vasospasm.

H Kurihara1, K Yamaoki, R Nagai, M Yoshizumi, F Takaku, H Satoh, J Inui, Y Yazaki.   

Abstract

Endothelin, administered into the coronary arteries of anesthetized dogs, produced a profound and long-lasting reduction in coronary blood flow with electrocardiographical evidence of myocardial ischemia. Coronary angiography revealed delayed filling of the distal branches and, in some cases, cessation of the blood flow distal to the epicardial portions of coronary arteries. The coronary vasoconstriction induced by endothelin subsided after intracoronary administration of nitroglycerin. Pretreatment with the Ca2+-channel antagonist, nitrendipine, suppressed endothelin-induced vasoconstriction. These findings suggest that endothelin, produced by vascular endothelial cells, may contribute to the pathogenesis of coronary vasospasm.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661945     DOI: 10.1016/0024-3205(89)90406-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Role of endogenous endothelin in the regulation of basal coronary tone in the rat.

Authors:  A T Goodwin; M Amrani; C C Gray; J Jayakumar; M H Yacoub
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

Review 2.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Coronary artery spasm induced by respiratory alkalosis.

Authors:  Arifumi Kohyama; Masaaki Uno; Toshihiko Doi; Takao Saito
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

Review 4.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

Review 5.  Biomarkers in acute myocardial infarction.

Authors:  Daniel Chan; Leong L Ng
Journal:  BMC Med       Date:  2010-06-07       Impact factor: 8.775

6.  Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  ET-1-associated vasomotion and vasospasm in lymphatic vessels of the guinea-pig mesentery.

Authors:  Jun Zhao; Dirk F van Helden
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

8.  Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.

Authors:  E G McMahon; M A Palomo; W M Moore; J F McDonald; M K Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 9.  Circadian control of human cardiovascular function.

Authors:  Saurabh S Thosar; Steven A Shea
Journal:  Curr Opin Pharmacol       Date:  2021-02-19       Impact factor: 5.547

10.  Comparison of the effects of intravenously bolus-administered endothelin-1 and infused angiotensin II on the subcutaneous tumor blood flow in anesthetized rats.

Authors:  S Tanda; K Hori; S Saito; M Shinozaki; Q H Zhang; M Suzuki
Journal:  Jpn J Cancer Res       Date:  1991-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.